Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.
D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000097:blood / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007630:Kenya; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000097:blood / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*; D013636:Tanzania; D014195:Travel
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine